DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Holdings Boosted by Nuance Investments LLC

Nuance Investments LLC raised its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,545,981 shares of the medical instruments supplier’s stock after buying an additional 2,708,097 shares during the quarter. DENTSPLY SIRONA makes up approximately 10.4% of Nuance Investments LLC’s investment portfolio, making the stock its largest position. Nuance Investments LLC owned about 6.81% of DENTSPLY SIRONA worth $257,103,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of XRAY. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock valued at $275,218,000 after buying an additional 348,532 shares during the period. Cooke & Bieler LP lifted its holdings in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock valued at $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. FMR LLC grew its position in DENTSPLY SIRONA by 5.1% in the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock worth $245,076,000 after acquiring an additional 436,031 shares during the period. Finally, Pacer Advisors Inc. raised its position in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after purchasing an additional 4,473,972 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $15.57 on Wednesday. The stock’s 50-day simple moving average is $17.86 and its 200-day simple moving average is $20.40. The firm has a market capitalization of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a fifty-two week low of $14.78 and a fifty-two week high of $33.42. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.07%.

Insider Activity at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.52% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on XRAY. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Evercore ISI restated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Mizuho lowered their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Finally, Wells Fargo & Company decreased their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.